# Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients

> **NCT03850886** · PHASE2 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 61 (actual)

## Conditions studied

- Non Alcoholic Fatty Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Niacinamide Oral Tablet
- **DRUG:** Antidiabetic

## Key facts

- **NCT ID:** NCT03850886
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-15
- **Primary completion:** 2019-08-07
- **Final completion:** 2019-08-07
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2020-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03850886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03850886, "Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03850886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*